Key result
Physician prediction of 1-year mortality during angiography is linked to ~9-fold higher actual mortality.
Why the study?
Physician perception of procedural risk affects revascularization decisions, and public reporting of PCI outcomes accentuates the need for accurate risk prediction to avoid undertreating the highest-risk patients.
Does physician prediction accurately predict 1-year mortality compared to the NYPCIRS score in patients undergoing invasive angiography?
Cohort (n=3,792)
Does physician prediction accurately predict 1-year mortality compared to the NYPCIRS score in patients undergoing invasive angiography?
Physician prediction of 1-year mortality is highly specific and accurate, and combining it with the objective NYPCIRS score improves overall mortality prediction in the cath lab.
Answers are grounded in this paper and cite their sources.
Physician prediction may aid real-time risk stratification in the cath lab; leaves open incremental value over NYPCIRS in prospective models.
BACKGROUND: Physician perception of procedural risk and clinical outcome can affect revascularization decision making. Public reporting of percutaneous coronary intervention outcomes accentuates the need for accuracy in risk prediction in order to avoid a treatment paradox of undertreating the highest risk patients. Our study compares a validated risk score to physician prediction (PP) of 1-year mortality based on clinical impression at the time of invasive angiography. METHODS AND RESULTS: We performed a cohort study between August 2015 and May 2018 to determine the discriminative accuracy of interventional cardiologists on one-year mortality of the treated patient. PP of one-year mortality was compared to the New York State Percutaneous Coronary Intervention Reporting System (NYPCIRS) score in predicting mortality. Three thousand seven hundred ninety-two patients were followed with a median follow-up period of 14.4 months (interquartile range 12.4-18.1 months) and 165 patients (4.4%) died within one-year. PP of mortality was associated with one-year mortality with a hazard ratio of 8.78 (95% confidence interval 5.24-14.71, P < 0.0001). Clinical presentation in the form of cardiogenic shock, return of spontaneous circulation, and liver and renal dysfunction were associated with PP. Diagnostic accuracy and specificity were improved in PP compared to NYPCIRS. The combination of PP to NYPCIRS improved the overall c-statistic and diagnostic yield. CONCLUSION: PP appears to be especially specific and accurate for prediction of mortality compared to NYPCIRS though it lacks sensitivity. Furthermore, the combination of PP with NYPCIRS improved the c-statistic and diagnostic yield. Overall, the utility of PP with an objective risk score improves the diagnostic accuracy of mortality prediction.
No takes yet. Share an insight, caveat, or question.
Sarathy et al. (2020) conducted a cohort in Patients undergoing invasive angiography (n=3,792). Physician prediction of 1-year mortality vs. New York State Percutaneous Coronary Intervention Reporting System (NYPCIRS) score was evaluated on 1-year mortality (HR 8.78, 95% CI 5.24-14.71, p=<0.0001). Physician prediction of 1-year mortality during invasive angiography was strongly associated with actual 1-year mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: